Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Flatt

Showing results (91-100 of 281) with videos related to

Pageof 29
Sort By:
Diabete & Metabolisme|December 1, 1986
Gastric inhibitory polypeptide and the entero-insular axis in streptozotocin diabetic miceC J Bailey, P R Flatt, P Kwasowski, et al.
Acta Endocrinologica|September 1, 1986
Hormonal modification of the growth and metabolic effects of a transplantable rat insulinomaP R Flatt, C J Bailey, S K Swanston-Flatt
Diabetes, Obesity & Metabolism|February 8, 2013
Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed miceN Irwin, K Hunter, I A Montgomery, et al.
Biochemical Society Transactions|February 1, 1997
Islet antioxidant and second phase enzyme levels following CYP1A, CYP2E, CYP2B and CYP4A inductionJ Clarke, J Coulter, P R Flatt, et al.
Biochemical Pharmacology|January 26, 1993
Sex differences in the diabetes-induced modulation of rat hepatic cytochrome P450 proteinsC R Barnett, S Rudd, P R Flatt, et al.
European Journal of Pharmacology|December 7, 1995
Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker ratA Irizar, C R Barnett, P R Flatt, et al.
Diabetes Research (Edinburgh, Scotland)|February 1, 1990
Stimulatory effects of glucagon-like peptides on human insulinoma cells and insulin-releasing clonal RINm5F cellsP R Flatt, O Shiber, S M Hampton, et al.
Molecular and Cellular Endocrinology|December 3, 2014
Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed miceV Pathak, V A Gault, P R Flatt, et al.
Bioscience Reports|August 1, 1985
Effects of fatty acid chain length and saturation on gastric inhibitory polypeptide release in obese hyperglycaemic (ob/ob) miceP Kwasowski, P R Flatt, C J Bailey, et al.
The Journal of Nutrition|December 29, 1999
The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitroA M Gray, Y H Abdel-Wahab, P R Flatt
Pageof 29

Showing results (91-100 of 281) with videos related to

Sort By:
Pageof 29
Diabete & Metabolisme|December 1, 1986
Gastric inhibitory polypeptide and the entero-insular axis in streptozotocin diabetic miceC J Bailey, P R Flatt, P Kwasowski, et al.
Acta Endocrinologica|September 1, 1986
Hormonal modification of the growth and metabolic effects of a transplantable rat insulinomaP R Flatt, C J Bailey, S K Swanston-Flatt
Diabetes, Obesity & Metabolism|February 8, 2013
Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed miceN Irwin, K Hunter, I A Montgomery, et al.
Biochemical Society Transactions|February 1, 1997
Islet antioxidant and second phase enzyme levels following CYP1A, CYP2E, CYP2B and CYP4A inductionJ Clarke, J Coulter, P R Flatt, et al.
Biochemical Pharmacology|January 26, 1993
Sex differences in the diabetes-induced modulation of rat hepatic cytochrome P450 proteinsC R Barnett, S Rudd, P R Flatt, et al.
European Journal of Pharmacology|December 7, 1995
Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker ratA Irizar, C R Barnett, P R Flatt, et al.
Diabetes Research (Edinburgh, Scotland)|February 1, 1990
Stimulatory effects of glucagon-like peptides on human insulinoma cells and insulin-releasing clonal RINm5F cellsP R Flatt, O Shiber, S M Hampton, et al.
Molecular and Cellular Endocrinology|December 3, 2014
Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed miceV Pathak, V A Gault, P R Flatt, et al.
Bioscience Reports|August 1, 1985
Effects of fatty acid chain length and saturation on gastric inhibitory polypeptide release in obese hyperglycaemic (ob/ob) miceP Kwasowski, P R Flatt, C J Bailey, et al.
The Journal of Nutrition|December 29, 1999
The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitroA M Gray, Y H Abdel-Wahab, P R Flatt
Pageof 29